Skip to main content
Clinical Trials/IRCT20210713051881N1
IRCT20210713051881N1
Recruiting
Phase 3

Evaluation of the effect of adding dexmedetomidine to del-Nido cardioplegia solution on myocardial protection in patients undergoing mitral valve replacement / repair

Mashhad University of Medical Sciences0 sites56 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Evaluation of the effect of adding dexmedetomidine to del-Nido cardioplegia solution on myocardial protection in patients undergoing mitral valve replacement / repair.
Sponsor
Mashhad University of Medical Sciences
Enrollment
56
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Candidate patients for mitral valve repair or replacement with ejection fraction above 40%

Exclusion Criteria

  • History of supraventricular dysrhythmias
  • History of heart surgery
  • Nephropathy following the use of contrast agent (CIN)
  • Persistent respiratory problems
  • Patients with a history of Stroke and TIA
  • Patients with a history of Coagulopathy
  • Use an intra\-aortic balloon pump (IABP) before and during surgery
  • Use vasopressor before surgery
  • Patient dissatisfaction to participate in the study
  • The presence of any pathological disorder leading to the release of inflammatory cytokines

Outcomes

Primary Outcomes

Not specified

Similar Trials